1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Regulus Therapeutics Inc (RGLS)
  7. News

RGLS

Regulus Therapeutics News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.065 14.61% 0.51 19:59:29
Open Price Low Price High Price Close Price Prev Close
0.45 0.443 0.507 0.5018 0.445
more quote information »

Recent News

Date Time Source Heading
10/26/20212:00IHNWFeaturedKWESST Announces New System to Counter Loitering Munition Drones
10/26/20212:00IHNWFeaturedLogiq's Advanced Consumer Scoring Technology Driving New Customer Program Offering Ramp-Up
10/26/20219:44IHNWFeaturedCybin Announces FDA Investigational New Drug Authorization of Cybin's Sponsored Feasibility Study Using Kernel Flow Technology
10/26/20218:30IHNWFeaturedCoroWare Subsidiary, CarbonMeta Research Ltd, Appoints Board of Director Members
10/26/20218:10IHNWFeaturedLomiko Appoints New Management Team and Director and Initiates a New Vision and Strategy in Quebec
10/26/20217:30IHNWFeaturedAmerican Green, Inc.™ (OTC:ERBB) Expands into Florida with Two AG Xpress™ CBD Facial Recognition Vending Machines for Simon "Premium Outlet" Mall St. Augustine Florida
10/12/202116:31EDGARCurrent Report Filing (8-k)
10/12/202116:05PRNUSRegulus Therapeutics Announces Strategic Prioritization of..
9/30/202116:55PRNUSRegulus Therapeutics' Director David Baltimore Receives 2021..
9/09/202116:40PRNUSRegulus Therapeutics to Present at the H.C. Wainwright 23rd..
8/10/202116:56EDGARQuarterly Report (10-q)
8/10/202116:16EDGARCurrent Report Filing (8-k)
8/10/202116:05PRNUSRegulus Therapeutics Reports Second Quarter 2021 Financial..
8/10/202116:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/03/202117:15PRNUSRegulus Therapeutics Announces Timing for Second Quarter..
6/25/202108:38SEEKRegulus Therapeutics reports additional RGLS4326 data in..
6/25/202107:05PRNUSRegulus Therapeutics Presents Additional Data from its..
6/21/202107:00PRNUSRegulus Therapeutics to Present Additional Data from its..
6/16/202116:02EDGARCurrent Report Filing (8-k)
6/15/202116:47EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:46EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:45EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:44EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:44EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:43EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:41EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202116:40EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202116:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/21/202116:08EDGARCurrent Report Filing (8-k)
5/21/202111:51SEEKRegulus reports mixed results in early-stage trial for..
5/21/202108:07PRNUSRegulus Therapeutics Announces Incremental Update of..
5/17/202119:14EDGARStatement of Changes in Beneficial Ownership (4)
5/17/202119:13EDGARStatement of Changes in Beneficial Ownership (4)
5/14/202116:07PRNUSRegulus Therapeutics to Present at the Oppenheimer Rare &..
5/14/202106:04EDGARQuarterly Report (10-q)
5/13/202116:35SEEKRegulus Therapeutics EPS beats by $0.01
5/13/202116:16EDGARCurrent Report Filing (8-k)
5/13/202116:07PRNUSRegulus Therapeutics Reports First Quarter 2021 Financial..
5/06/202117:15PRNUSRegulus Therapeutics Announces Timing for First Quarter 2021..
5/03/202108:24SEEKRegulus reports top-line data from early-stage RGLS4326..
5/03/202108:17EDGARCurrent Report Filing (8-k)
5/03/202108:00PRNUSRegulus Therapeutics Announces Top-Line Data from the First..
4/30/202109:04EDGARProxy Statement (definitive) (def 14a)
4/16/202116:21EDGARStatement of Changes in Beneficial Ownership (4)
4/16/202116:15EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
4/15/202108:35SEEKRegulus Therapeutics completes dosing in early-stage kidney..
4/15/202108:07PRNUSRegulus Therapeutics Announces Completion of Dosing in the..
4/07/202108:07PRNUSRegulus Therapeutics to Present at the 20th Annual Needham..
3/12/202111:00SEEKNLS Pharmaceutics, Entera Bio leads healthcare gainers;..
3/10/202106:04EDGARSecurities Registration Statement (simplified Form) (s-3)
3/09/202117:34EDGARAnnual Report (10-k)
3/09/202116:31EDGARCurrent Report Filing (8-k)
3/09/202116:29SEEKRegulus Therapeutics EPS of -$0.03
3/09/202116:07PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
3/08/202111:05EDGARStatement of Ownership (sc 13g)
3/05/202116:07PRNUSRegulus Therapeutics to Present at the H.C. Wainwright..
See more news about this stock »


Your Recent History
NASDAQ
RGLS
Regulus Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.